DirectHaler™ Nasal is both a device innovation and delivery method innovation. Performance and characteristics are confirmed in clinical trials (pre-clinical and Phase I) and invitro documentation.

We would be pleased to compile and make technical documentation available for you to evaluate.

Please contact Dr. Troels Keldmann for more details.